10mw
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 25 ((3'r)-1'-{(1p)-5-amino-1-[2-(trifluoromethoxy)phenyl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one)
3D- Structure doesn't exist.
